Pulseless disease is a rare disease that manifests itself in the absence or significantly decreased pulse of the patient (bradycardia), as well as in disturbances in the rhythm and frequency of the heart. As a rule, it is severe and can lead to complications such as heart failure, arrhythmia and even cardiac arrest.
According to research, pulselessness disease occurs in approximately one person out of one hundred million people on the planet, but exact data on its prevalence among patients is unknown. Most cases of the disease occur in people aged 50 to 80 years, but this condition is first diagnosed in children.
The main causes of pulseless disease are various pathologies of the heart and blood vessels. These may be congenital anomalies of the structure of the cardiovascular system, coronary heart disease, heart defects, cardiomyopathies, myocarditis, syphilis, sclerosis, post-infarction syndrome, post-myocarditis syndrome and others. Complications associated with pulseless disease include tuberculosis, rheumatic diseases, fever, cerebral hemorrhages, shock, severe infections and toxic effects on the body.
As a rule, to identify pulseless disease, a long-term examination of the patient is required, including ECHO-CG, blood tests for biochemical parameters, as well as for thyroid hormones, and immunological tests. When performing an electrocardiogram (ECG), the absence or low number of pulse waves is determined. Also, with the help of physical activity, the threshold heart rate (HR) is determined, after which the intensity of heart contractions decreases significantly.